This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovations of Jae Kim
Introduction
Jae Kim is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of siRNAs. His work is pivotal in developing new methods for treating diseases.
Latest Patents
Jae Kim holds a patent for his invention titled Tunable Reversir™ compounds. This invention relates to agents that modulate the pharmacological activity of siRNAs. Additionally, it encompasses methods and systems for assessing the efficacy and safety of pharmaceutical compositions for disease treatment or prophylaxis. He has 1 patent to his name.
Career Highlights
Jae Kim is currently employed at Alnylam Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on advancing therapeutic solutions that can significantly impact patient care.
Collaborations
Throughout his career, Jae has collaborated with notable colleagues, including Ivan Zlatev and Adam Castoreno. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions.
Conclusion
Jae Kim's contributions to the field of pharmaceuticals through his innovative inventions and collaborations highlight his role as a key figure in advancing medical science. His work continues to pave the way for new therapeutic approaches.